Hugo Gregório
Hugo Gregório
CHV- Centro Hospitalar Veterinário, Porto
Email confirmado em chv.pt - Página inicial
TítuloCitado porAno
COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer
FL Queiroga, I Pires, M Parente, H Gregório, CS Lopes
The Veterinary Journal 189 (1), 77-82, 2011
702011
Prognostic value of tumour‐associated macrophages in canine mammary tumours
T Raposo, H Gregorio, I Pires, J Prada, FL Queiroga
Veterinary and comparative oncology 12 (1), 10-19, 2014
262014
Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors
MI Carvalho, I Pires, J Prada, H Gregório, L Lobo, FL Queiroga
Veterinary immunology and immunopathology 178, 1-9, 2016
152016
Evaluation of cyclooxygenase-2 expression in canine mast cell tumours
J Prada, FL Queiroga, H Gregório, I Pires
Journal of comparative pathology 147 (1), 31-36, 2012
142012
High COX‐2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival …
MI Carvalho, I Pires, J Prada, TP Raposo, H Gregório, L Lobo, ...
Veterinary and comparative oncology 15 (2), 619-631, 2017
92017
High COX‐2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival
H Gregório, T Raposo, FL Queiroga, I Pires, L Pena, J Prada
Veterinary and comparative oncology 15 (4), 1382-1392, 2017
82017
Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours
H Gregório, TP Raposo, FL Queiroga, J Prada, I Pires
Melanoma research 26 (4), 338-347, 2016
62016
Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.
MI Carvalho, I Pires, M Dias, J Prada, H Gregório, L Lobo, F Queiroga
Analytical Cellular Pathology 2015, 2015
62015
Comparison of veterinary health services expectations and perceptions between oncologic pet owners, non-oncologic pet owners and veterinary staff using the SERVQUAL methodology
H Gregório, I Santos, P, Pires, J Prada, FL Queiroga
Veterinary World 9 (11), 1275-1278, 2016
42016
Mammary invasive micropapillary carcinoma in a male cat: Immunohistochemical description and clinical follow-up
H Gregório, I Pires, F Seixas, F Queiroga
Acta Veterinaria Hungarica 60 (2), 257-261, 2012
22012
Assessing the Interleukin 35 Immunoexpression in Malignant Canine Mammary Tumors: Association With Clinicopathological Parameters and Prognosis
MI Carvalho, I Pires, J Prada, C Pinto, H Gregorio, B Cogliati, FL Queiroga
Anticancer Research 39 (4), 2077-2083, 2019
2019
STUDY OF THE MECHANISMS BEHIND COX-2 EXPRESSION IN CANINE MELANOCYTIC TUMOURS
I Pires, J Gomes, J Prada, H Gregorio, F Queiroga
Journal of Veterinary Internal Medicine 29 (1), 457-458, 2015
2015
ROLE OF CYCLOOXIGENASE-2 IN PROGNOSIS OF CANINE MAST CELL TUMOURS
H Gregorio, J Prada, I Pires, F Queiroga
Journal of Veterinary Internal Medicine 29 (1), 481-482, 2015
2015
NEW INSIGHTS INTO COX-2 PATHWAYS IN CANCER: THE DOG AS A PROMISING MODEL
FL Queiroga, MI Carvalho, T Raposo, J Prada, H Gregorio, I Pires
ANTICANCER RESEARCH 34 (10), 6125-6125, 2014
2014
USE OF METRONOMIC PROTOCOLS IN THE TREATMENT OF SEVERAL END-STAGE DOG CANCERS: A NEW APPROACH AND IMPLICATIONS AS A MODEL FOR HUMAN DISEASE
H Gregorio, I Pires, J Prada, FL Queiroga
ANTICANCER RESEARCH 34 (10), 6124-6125, 2014
2014
Firocoxib palliative treatment in dogs with end stage cancer: impact on their quality of life
H Gregório, J Prada, I Pires, F Queiroga
Veterinary and Comparative Oncology 11 (3), 2013
2013
La función de los inhibidores de la COX-2 en oncología veterinaria
FL Queiroga, H Gregório
Consulta de difusión veterinaria 21 (197), 33-36, 2013
2013
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–17